Indo Rama Synthetics (India) Limited (INDORAMA)
Outcome of Board Meeting
FY26 results (audited):
Standalone:
Revenue 4.5187tn +x% y-y (x tn)
PAT 110.03bn +x% y-y (x bn)
Consolidated:
Revenue 4.9101tn +x% y-y (x tn)
PAT 150.21bn +x% y-y (x bn)
Q1FY27 results (unaudited):
Standalone:
Revenue 817.51bn
PAT 33.75bn
Consolidated:
Revenue 936.64bn
EBITDA 108.04bn
EBITDA margin 11.5%
PAT 63.74bn
Dividend: None stated
Commentary: Q1/FY27 total income decreased 28.15% y-y due to West Asia geopolitical issues; EBITDA improved due to better margins and product mix.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 INDORAMA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add INDORAMA to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Indo Rama Synthetics (India) Limited
Important.
The summary above is generated automatically from Indo Rama Synthetics (India) Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.